quarta-feira, 7 de outubro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 16, 2026

Disney Stock Price Prediction: Where Will The Stock be In 2027?

View original at finance.yahoo.com
“The sell-off was amplified by a 77.07% plunge in operating cash flow to $735 million, driven largely by accelerated tax payments tied to California wildfire disaster relief, reflecting a one-time timing item rather than any change in underlying business performance.”
Verbatim excerpt from the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Strong fundamental visibility and broad institutional support justifies 90% confidence level

    60% confidence

  • Management guided for double-digit adjusted EPS growth in both FY2026 and FY2027

    60% confidence

  • Disney price target is $116.32 with 15.06% upside from current price of $101.10

    60% confidence

  • Management targeting a 10% SVOD operating margin for the full year FY2026

    60% confidence

  • Disney stock rating is BUY with 90% confidence level

    60% confidence

  • 84% of covering analysts rated bullish on Disney

    60% confidence

  • Operating cash flow plunge was driven by accelerated tax payments tied to California wildfire disaster relief, reflecting a one-time timing item rather than any change in underlying business performance

    60% confidence

Data points we hold from this source

The Walt Disney Company · stock price101.10 USD
The Walt Disney Company · experiences revenue10 USD
The Walt Disney Company · experiences operating income3.3 USD
The Walt Disney Company · eps1.63 USD
The Walt Disney Company · operating cash flow735 USD
The Walt Disney Company · streaming operating income450 USD
The Walt Disney Company · total streaming subscribers196 millions
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Disney Stock Price Prediction: Where Will The Stock be In 2027? — Source | Via News | pt.VIA.NEWS